Central line-associated bloodstream infections (CLABSIs) are the most common hospital-acquired infection in pediatric patients. The average cost is over $55,000 per infection. What is the most successful strategy to reduce that?
Augustine Chemparathy; Martin G. Seneviratne, MD; Andrew Ward, PhD; Simran Mirchandani, MS; Ron Li, MD; Roshni Mathew, MD; Matthew Wood, PhD; Andrew Y. Shin, MD; Lane F. Donnelly, MD; David Scheinker, PhD; Grace M. Lee, MD, MPH
From the Department of Management Science and Engineering, Stanford University, Stanford, Calif.; Department of Biomedical Informatics, Stanford University, Stanford, Calif.; Department of Electrical Engineering, Stanford University School of Engineering, Stanford, Calif.; Center for Biomedical Informatics Research, Stanford University School of Medicine, Stanford, Calif.; and Lucile Packard Children’s Hospital, Stanford University, Stanford, Calif.
*Corresponding author. Address Grace M. Lee, MD, MPH, Lucile Packard Children’s Hospital, Stanford University, 300 Pasteur Dr # H-306A, Stanford, CA 94305-2200PH: (650) 498-6227; Fax: (650) 725-8040 Email: gmlee@stanford.edu David Scheinker and Grace M. Lee are co-senior authors on this work.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
To cite: Chemparathy A, Seneviratne MG, Ward A, Mirchandani S, Li R, Mathew R, Wood M, Shin AY, Donnelly LF, Scheinker D, Lee GM. Development and Implementation of a Real-time Bundle-adherence Dashboard for Central Line-associated Bloodstream Infections. Pediatr Qual Saf 021;6:e431.
Received for publication July 18, 2020;
Accepted January 6, 2021.Published online June 23, 2021
DOI: 10.1097/pq9.0000000000000431
